What is Entero Therapeutics Inc. Price to Earning Ratio?

Entero Therapeutics Inc. Price to Earning Ratio is -0.1, which is negative.

What is Entero Therapeutics Inc. Stock Price?

Entero Therapeutics Inc. Stock Price fell 87.05% and underperformed its sector by 96% in the past year.

What is Entero Therapeutics Inc. Mutual Fund Holding?

Entero Therapeutics Inc. Mutual Fund Holding decreased by 0.01% in the last quarter to 0.79.

What is Entero Therapeutics Inc. Institutional Holding?

Entero Therapeutics Inc. Institutional Holding remained the same in the last quarter at 1.52%.

How is the Entero Therapeutics Inc. today?

The Entero Therapeutics Inc. today is trading in the green, up by 2.86% at 0.36.

How has Entero Therapeutics Inc. performed historically?

The Entero Therapeutics Inc. is currently trading up 2.86% on an intraday basis in the past week the index fell -12.20%. The index has been down -34.55% in the past quarter and fell -87.05% in the past year. You can view this in the overview section.

Entero Therapeutics Inc. XNAS: ENTO

Entero Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Entero Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Entero Therapeutics Inc.
Rating: 0.82950
Author: Trendlyne DVM scores

Download real time

0.36 0.01 (2.86%)

88.61% Fall from 52W High

60,075 XNAS Volume

XNAS 22 Apr, 2025 4:03 PM (EDT)

Board Meeting

The next board meeting for Entero Therapeutics Inc. is on 28 Apr 2025 for the purpose of Entero Therapeutics Inc Annual General Meeting for 2024 See details

Entero Therapeutics Inc. Key Metrics

My Metrics

Select

Market Capitalization Low in industry Unavailable in chosen country	1.7
PE TTM Negative PE TTM Unavailable in chosen country	-0.1
Price to Book Low in industry Unavailable in chosen country	0.2
Institutional holding current Qtr % Low in industry Unavailable in chosen country	1.5
Rel Perf vs Sector quarter% Unavailable in chosen country	-33.8

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

16.0 / 100

Technically Bearish

17.2 / 100

No estimates available

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

Entero Therapeutics Inc. Stock Price Analysis

Day Price Range 2.9% 1 Day return Unavailable in chosen country	0.4 (LTP) 0.30.4 LowHigh
Week Price Range -12.2% 1 Week return Unavailable in chosen country	0.4 (LTP) 0.30.4 LowHigh
Month Price Range -41.0% 1 Month return Unavailable in chosen country	0.4 (LTP) 0.30.6 LowHigh
52 Week Price Range -87.0% 1 Year return Unavailable in chosen country	0.4 (LTP) 0.23.2 LowHigh

View full Share Price History

Entero Therapeutics Inc. Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Entero Therapeutics Inc. Stock Analysis

Entero Therapeutics Inc. stock analysis with key metrics, changes, and trends.

Entero Therapeutics Inc. Metric	VALUE	CHANGE %	TREND	ANALYSIS
Price to Earning Ratio	-0.1	-	negative	Price to Earning Ratio is -0.1, which is negative.
Stock Price	$0.36	-87.05%	negative	Stock Price fell 87.05% and underperformed its sector by 96% in the past year.
Mutual Fund Holding	0.79 %	-0.01%	negative	Mutual Fund Holding decreased by 0.01% in the last quarter to 0.79.
Institutional Holding	1.52 %	0%	neutral	Institutional Holding remained the same in the last quarter at 1.52%.

Loading data..

Entero Therapeutics Inc. - Company Profile

Gross Remuneration

2025

Gross Remuneration

Year

Entero Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

88.61% Fall from 52W High

Entero Therapeutics Inc. Key Metrics

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Rel Perf vs Sector quarter%

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Rel Perf vs Sector quarter%

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Entero Therapeutics Inc. Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Entero Therapeutics Inc. Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Entero Therapeutics Inc. Stock Analysis

Entero Therapeutics Inc. stock analysis with key metrics, changes, and trends.

Price to Earning Ratio is -0.1, which is negative.

Stock Price fell 87.05% and underperformed its sector by 96% in the past year.

Mutual Fund Holding decreased by 0.01% in the last quarter to 0.79.

Institutional Holding remained the same in the last quarter at 1.52%.

Entero Therapeutics Inc. - Company Profile

Entero Therapeutics Inc. Management structure

Mr. James Sapirstein

Chief Executive Officer

Mr. Richard Joel Paolone

Interim Chief Executive Officer and Chairman of the Board

Ms. Sarah M. Romano

Chief Financial Officer and Principal Accounting Officer

Ms. Anna Skowron, C.A.,C.P.A.

Chief Financial Officer

Dr. Jack Syage, PhD

Director and President

Entero Therapeutics Inc. Board of directors

Dr. Alastair James Riddell

Independent Director

Mr. Richard Joel Paolone

Interim Chief Executive Officer and Chairman of th

Mr. Timothy R. Ramdeen

Director

Mr. Manpreet Uppal

Director

Mr. Alson Niu

Director

Mr. Eric Corbett

Director

Entero Therapeutics Inc. FAQ

How is Entero Therapeutics Inc. today?

Entero Therapeutics Inc. today is trading in the green, and is up by 2.86% at 0.36.

How has Entero Therapeutics Inc. performed historically?

Entero Therapeutics Inc. is currently trading up 2.86% on an intraday basis. In the past week the stock fell -12.20%. stock has been down -34.55% in the past quarter and fell -87.05% in the past year. You can view this in the overview section.